New pilot plant for SVPs within limited space

The R&D division of the largest US based healthcare company located in the northern part of Switzerland needed a new facility for SVPs built onto its existing site. NNE Pharmaplan’s innovative and creative approach led to the successful development of an optimal new facility.

In order to have sufficient capacity for pilot plant production, the customer decided to build a new facility directly onto an existing building. The new site produces bulk and pre-filled syringes as well as liquid and freeze-dried vials in pilot scale.

Aware of NNE Pharmaplan’s reputation for extensive process and equipment know-how in the production of SVPs (small volume parenterals) and, in particular, in fill and finish technology, the pharmaceutical company called on NNE Pharmaplan to assist in the process design, equipment selection and engineering of the new site layout.

Optimal solution despite limited space
With on-going, in-depth and close communication with the customer, NNE Pharmaplan’s experts achieved an optimum layout solution - despite the key challenge of limited available space.

NNE Pharmaplan carefully designed all process areas to ensure future easy maintenance of the systems from non-GMP areas and floor space was reduced to a minimum thereby maximising process areas.

NNE Pharmaplan’s creative and innovative approach was key to making this project a success.

 

Download the case story in PDF